KM
Kalos Management Portfolio holdings
AUM
$46.6M
1-Year Return
11.52%
This Quarter Return
+4.68%
1 Year Return
+11.52%
3 Year Return
+47.83%
5 Year Return
+70.92%
10 Year Return
–
AUM
$186M
AUM Growth
-$34.1M
(-15%)
Cap. Flow
-$39.3M
Cap. Flow
% of AUM
-21.09%
Top 10 Holdings %
Top 10 Hldgs %
33.45%
Holding
233
New
32
Increased
46
Reduced
81
Closed
70
Top Buys
| 1 |
iShares S&P 500 Growth ETF
IVW
|
$8.39M |
| 2 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
$6.69M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$6.63M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$2.97M |
| 5 |
JPMorgan Chase
JPM
|
$2.9M |
Top Sells
| 1 |
Schwab US Large- Cap ETF
SCHX
|
$5.6M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$5.05M |
| 3 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
$4.71M |
| 4 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
$4.59M |
| 5 |
iShares US Basic Materials ETF
IYM
|
$4.24M |
Sector Composition
| 1 | Technology | 13.18% |
| 2 | Healthcare | 12.33% |
| 3 | Financials | 8.49% |
| 4 | Consumer Discretionary | 6.57% |
| 5 | Industrials | 3.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares S&P 500 Value ETF
IVE
$41B
| $243K | 0.13% |
+2,103
| New | +$243K |
|
127
BioCryst Pharmaceuticals
BCRX
$1.74B
| $241K | 0.13% |
31,500
-1,000
| -3% | -$7.65K |
|
128
Coca-Cola
KO
$292B
| $241K | 0.13% |
5,148
-2,898
| -36% | -$136K |
|
129
Procter & Gamble
PG
$375B
| $239K | 0.13% |
2,749
-746
| -21% | -$64.9K |
|
130
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $238K | 0.13% |
+5,915
| New | +$238K |
|
131
Boeing
BA
$174B
| $233K | 0.13% |
627
-180
| -22% | -$66.9K |
|
132
Ventas
VTR
$30.9B
| $224K | 0.12% |
3,759
-7,296
| -66% | -$435K |
|
133
Mastercard
MA
$528B
| $221K | 0.12% |
+1,036
| New | +$221K |
|
134
Chevron
CVX
$310B
| $219K | 0.12% |
1,798
-312
| -15% | -$38K |
|
135
Alphabet (Google) Class A
GOOGL
$2.84T
| $214K | 0.11% |
3,640
-4,680
| -56% | -$275K |
|
|
136
SPDR S&P 500 ETF Trust
SPY
$660B
| $212K | 0.11% |
759
-18,094
| -96% | -$5.05M |
|
137
Vanguard Growth ETF
VUG
$186B
| $207K | 0.11% |
+1,340
| New | +$207K |
|
138
Bank of America
BAC
$369B
| $202K | 0.11% |
6,983
-2,565
| -27% | -$74.2K |
|
139
Vanguard Value ETF
VTV
$143B
| $200K | 0.11% |
+1,835
| New | +$200K |
|
140
Invesco DB Commodity Index Tracking Fund
DBC
$1.26B
| $196K | 0.11% |
+11,146
| New | +$196K |
|
141
Gyre Therapeutics
GYRE
$698M
| $180K | 0.1% |
2,308
+1,175
| +104% | +$91.6K |
|
142
Cytosorbents Corp
CTSO
$60.6M
| $176K | 0.09% |
14,700
-2,950
| -17% | -$35.3K |
|
|
MAV
143
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
| $175K | 0.09% |
16,400
-866
| -5% | -$9.24K |
|
144
Invesco Municipal Trust
VKQ
$511M
| $165K | 0.09% |
14,750
| – | – |
|
145
GE Aerospace
GE
$296B
| $164K | 0.09% |
3,263
+932
| +40% | +$46.8K |
|
146
Verastem
VSTM
$663M
| $144K | 0.08% |
+1,875
| New | +$144K |
|
|
PHK
147
PIMCO High Income Fund
PHK
$857M
| $140K | 0.08% |
16,801
+3,848
| +30% | +$32.1K |
|
|
SNMP
148
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $138K | 0.07% |
652
+124
| +23% | +$26.2K |
|
149
Amicus Therapeutics
FOLD
$2.46B
| $126K | 0.07% |
+10,750
| New | +$126K |
|
|
ESV
150
DELISTED
Ensco Rowan plc
ESV
| $120K | 0.06% |
3,900
-812
| -17% | -$25K |
|